Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Leishmanial Antigens as Diagnostics
Reed, Steven Gregory
Corixa Corporation, Hamilton, WA, United States
Search 208 grants from Steven Reed
Search grants from Corixa Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A path to thrombosis in primary myelofibrosis
Genetic determinants of HSV-1 virulence in neurons
Identification of Critical Signaling Pathways Modulating Mast Cell Activation
Second Stage Labor Nursing Care with Epidural Anesthesia
Bone Density, Endogenous Hormones, & Breast Cancer Risk
Recently added grants:
Mechanisms of Protection and Durability for a Live Attenuated Tetravalent Dengue Vaccine
Liver Xenotransplantation using CRISPR-modified Porcine Organs
Metabolomics Core
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
Allergen T cell epitopes during the management of peanut allergic disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI036131-03
Application #
2004119
Study Section
Special Emphasis Panel (ZRG5-MBC-2 (01))
Project Start
1994-09-15
Project End
1997-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Corixa Corporation
Department
Type
DUNS #
City
Hamilton
State
WA
Country
United States
Zip Code
Related projects
NIH 1996
R44 AI
Development of Leishmanial Antigens as Diagnostics
Reed, Steven Gregory / Corixa Corporation
NIH 1995
R44 AI
Development of Leishmanial Antigens as Diagnostics
Reed, Steven Gregory / Corixa Corporation
Comments
Be the first to comment on Steven Reed's grant